Gland Pharma Limited → Xiromed Llc

Bill of Lading Import Record

Summary

The following Bill of Lading record outlines a container shipment imported into the US by XIROMED LLC. This shipment is registered as coming from GLAND PHARMA LIMITED via Nhava Sheva,India with logistic notifications handled by WALKER INTERNATIONAL TRANSPORTATION. Manifest records show a quanitity of 38 PKG with a total weight of 12653 Kilograms arrived on 2020-08-05 via the vessel MSC PARIS to the port of New York/Newark Area, Newark, New Jersey. Cargo includes products identified as 19 (nineteen packages only ) glycopyrrolate i njection , usp 0.2mg/ml, 5ml vial ( 1mg/5ml) neostigmine methy lsulfate injection, usp 0. 5mg/ml, 10ml vial (5mg/10m l) usp 1mg/ml, 10m l vial ( 10mg/10ml) h.s.code: 30049 099 inv: exp/p/056/20-21 d t: 29.06.2020 sb no: 35187 71 dt: 30.06.2020 freight prepaid = india tel.

Cargo Details
Consignee
XIROMED LLC
180 PARK AVE SUITE 101 FLORHAM PARK
SHREWSBURY NJ NJ 07932 UNITED STATE

Shipper
GLAND PHARMA LIMITED
PLOT NOS. 42-52, PHASE-III,,INDUSTR
HYDERABAD TG 502307 INDIA

Notify Party
WALKER INTERNATIONAL TRANSPORTATION
70 E. SUNRISE HIGHWAY, SUITE 604
VALLEY STREAM NY 11581 UNITED STATE



Vessel and Port
Carrier CodeMEDU
VesselMSC PARIS [LR]
Departure PortNhava Sheva,India
Landing PortNew York/Newark Area, Newark, New Jersey
Manifest Qty38 PKG
Manifest Weight12653 Kilograms
Manifest Dimension0
Place of ReceiptNHAVA SHEVA
Conveyance ID9301483 [IMO Number/Lloyds Number]
Transportation ModeVessel, containerized
Arrival Date2020-08-05
Container Cargo Description
Container #PiecesDescription
MSCU73186011919 (NINETEEN PACKAGES ONLY ) GLYCOPYRROLATE I NJECTION , USP 0.2MG/ML, 5ML VIAL ( 1MG/5ML) NEOSTIGMINE METHY LSULFATE INJECTION, USP 0. 5MG/ML, 10ML VIAL (5MG/10M L) USP 1MG/ML, 10M L VIAL ( 10MG/10ML) H.S.CODE: 30049 099 INV: EXP/P/056/20-21 D T: 29.06.2020 SB NO: 35187 71 DT: 30.06.2020 FREIGHT PREPAID = INDIA TEL
TRIU80122321919 (NINETEEN PACKAGES ONLY ) GLYCOPYRROLATE I NJECTION , USP 0.2MG/ML, 1ML VIAL ( 0.2MG/ML) USP 0.2MG/ML, 2M L VIAL (0.4MG/2ML) USP 0.2 MG/ML, 5ML VIAL (1MG/5ML) USP 0.2MG/ML, 20ML VIAL (4 MG/20ML) H.S.CODE: 3004909 9 INV: EXP /P/055/20-21 DT: 29.06.2020 SB NO: 3510322 DT : 30.06.2020
MSCU7318601NO MARKS NO MARKS NO MARKS NO MARKS NO MARKS NO MARKS NO MARKS NO MARKS
MSCU7318601NO MARKS NO MARKS NO MARKS
MSCU7318601NO MARKS NO MARKS NO MARKS NO MARKS NO MARKS NO MARKS NO MARKS NO MARKS
MSCU7318601NO MARKS NO MARKS NO MARKS
TRIU8012232NO MARKS NO MARKS NO MARKS NO MARKS NO MARKS NO MARKS NO MARKS
TRIU8012232NO MARKS NO MARKS NO MARKS NO MARKS NO MARKS NO MARKS NO MARKS
BoL Details
Master BOLHouse BOLVoyage NumberBill TypeManifest #Update / Run Date
MEDUMV055360 () 028ARegular Bill12020-08-05 / 2020-08-06
© 2024 import.report | Privacy Policy